Integrated Filing — IndAS

General information about company
Scrip Code	500153
NSE Symbol	GANESHBE
MSEI Symbol	NOTLISTED
ISIN	INE388A01029
Name of company	GANESH BENZOPLAST LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	14-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	07-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	14-May-2025   13:00:00
End date and time of board meeting	14-May-2025   17:25:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-05-14
Indicate Company website link for updated RPT policy of the Company	https://www.ganeshbenzoplast.com/Investors/PoliciesAndCodes
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	Yes
No. of times funds raised during the quarter	2
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
NOT APPLICABLE

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	575570000	2154010000
	Other income	46570000	168400000
	Total income	622140000	2322410000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	30360000	127410000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-94680000	-94680000
(d)	Employee benefit expense	64460000	234280000
(e)	Finance costs	20770000	65230000
(f)	Depreciation, depletion and amortisation expense	48620000	190210000
(f)	Other Expenses
1	Labour/Service charges, Freight,Warehousing and Handling charges, Repairs & Maintenance etc.	83720000	210710000
2	tConsumption of stores, spare & Packing material.	96170000	144350000
3	tPower and fuel	33120000	121240000
4	tLegal and Professional Fees	46270000	133220000
5	others	49830000	328520000
	Total other expenses	309110000	938040000
	Total expenses	378640000	1460490000
3	Total profit before exceptional items and tax	243500000	861920000
4	Exceptional items	-443780000	-443780000
5	Total profit before tax	-200280000	418140000
6	Tax expense
7	Current tax	-56150000	86510000
8	Deferred tax	14450000	24380000
9	Total tax expenses	-41700000	110890000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-158580000	307250000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-158580000	307250000
17	Other comprehensive income net of taxes	450000	-6640000
18	Total Comprehensive Income for the period	-158130000	300610000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	71990000	71990000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		5223410000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-2.2	4.27
	Diluted earnings (loss) per share from continuing operations	-2.2	4.27
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-2.2	4.27
	Diluted earnings (loss) per share from continuing and discontinued operations	-2.2	4.27
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		notes n n1. The above financial results of Ganesh Benzoplast Limited were reviewed by the audit committee and approved by the Board of Directors at their respective meetings held on 14th May 2025. The statutory auditors of the Company have conducted the audit of the above Standalone Financial Results for the quarter and year ended March 31, 2025. n n2.The above results of the Company have been prepared in accordance with the recognition and measurement principles and procedures laid down in Indian Accounting Standards 34 nterim Financial Reporting Ind AS 34 prescribed under section 133 of the Companies Act 2013 and other accounting principles generally accepted in India. n n3.Pursuant to the Settlement Agreement dated January 17, 2025, the Company has successfully concluded its legal dispute with Morgan Securities and Credits Pvt. Ltd. Morgan. Under the settlement terms the Company has paid one time sum of Rs. 438.63 million as full and final resolution. This settlement removes significant operational constraints previously imposed on the Company enabling it to focus on core business activities and pursue accelerated growth opportunities. Importantly, the Company maintains a strong liquidity position ensuring no material impact on its financial stability while securing a clear path forward for strategic initiatives. The Company has recognized a one-time GST liability of Rs. 5.15 million under GST Audit of Chemical division for 5 years. This amount has been classified as an exceptional item in the financial statements reflecting its non recurring nature. n n4.During the FY25 PAT without exceptional item is Rs. 645 million as compared to Rs. 606 million during FY24 with an increase of 6% YOY. EPS before exceptional item for FY25 is Rs. 9 as compared to Rs. 8.95 in FY24 with an increase of 0.6% YOY. n n5.The figures for the corresponding previous period have been regrouped / rearranged wherever necessary, to make them comparable.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	2820200000
	Capital work-in-progress	56740000
	Investment property	0
	Goodwill	0
	Other intangible assets	396320000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	676300000
	Trade receivables, non-current	0
	Loans, non-current	987530000
	Other non-current financial assets	166200000
	Total non-current financial assets	1830030000
	Deferred tax assets (net)
	Other non-current assets
	Total non-current assets	5103290000
2	Current assets
	Inventories	94680000
	Current financial asset
	Current investments	14600000
	Trade receivables, current	355730000
	Cash and cash equivalents	29170000
	Bank balance other than cash and cash equivalents	848680000
	Loans, current	166770000
	Other current financial assets
	Total current financial assets	1414950000
	Current tax assets (net)	111140000
	Other current assets	87020000
	Total current assets	1707790000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	6811080000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	71990000
	Other equity	5223410000
	Total equity attributable to owners of parent	5295400000
	Non controlling interest
	Total equity	5295400000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	419660000
	Total non-current financial liabilities	419660000
	Provisions, non-current	63600000
	Deferred tax liabilities (net)	180480000
	Deferred government grants, Non-current	0
	Other non-current liabilities	22310000
	Total non-current liabilities	686050000
	Current liabilities
	Current financial liabilities
	Borrowings, current	191820000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	17010000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	246670000
	Total Trade payable	263680000
	Other current financial liabilities	305510000
	Total current financial liabilities	761010000
	Other current liabilities	49970000
	Provisions, current	18650000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	829630000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	1515680000
	Total equity and liabilites	6811080000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	LST DIVISION INCLUDING EPC AND WHARFAGE	452410000	1660050000
2	CHEMICAL DIVISION	123160000	493950000
	Total Segment Revenue	575570000	2154000000
	Less: Inter segment revenue	0	0
	Revenue from operations	575570000	2154000000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	LST DIVISION INCLUDING EPC AND WHARFAGE	226930000	777070000
2	CHEMICAL DIVISION	36280000	143450000
	Total Profit before tax	263210000	920520000
	i. Finance cost	20770000	20770000
	ii. Other Unallocable Expenditure net off Unallocable income	-1080000	-1080000
	Profit before tax	243520000	861920000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	LST DIVISION INCLUDING EPC AND WHARFAGE	6331110000	6331110000
2	CHEMICAL DIVISION	368820000	368820000
	Total Segment Asset	6699930000	6699930000
	Un-allocable Assets	111150000	111150000
	Net Segment Asset	6811080000	6811080000
4	Segment Liabilities
	Segment Liabilities
1	LST DIVISION INCLUDING EPC AND WHARFAGE	1264640000	1264640000
2	CHEMICAL DIVISION	70560000	70560000
	Total Segment Liabilities	1335200000	1335200000
	Un-allocable Liabilities	180480000	180480000
	Net Segment Liabilities	1515680000	1515680000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	items that will not be reclassified to profit or loss	600000	-8880000
	Total Amount of items that will not be reclassified to profit and loss	600000	-8880000
2	Income tax relating to items that will not be reclassified to profit or loss	150000	-2240000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	450000	-6640000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			418140000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			0
	Adjustments for decrease (increase) in inventories			65230000
	Adjustments for decrease (increase) in trade receivables, current			-94680000
	Adjustments for decrease (increase) in trade receivables, non-current			16130000
	Adjustments for decrease (increase) in other current assets			-379890000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-150000
	Adjustments for increase (decrease) in trade payables, non-current			603730000
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			190210000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			0
	Adjustments for interest income			151410000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			1850000
	Other adjustments for non-cash items			310000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			251330000
	Net cash flows from (used in) operations			669470000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			157520000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			511950000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			-7240000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			372970000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			40990000
	Cash receipts from repayment of advances and loans made to other parties			-381610000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			151410000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			46720000
	Net cash flows from (used in) investing activities	-590200000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			0
	Payments of lease liabilities			0
	Dividends paid			0
	Interest paid			65230000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			63130000
	Net cash flows from (used in) financing activities			-2100000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-80350000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-80350000
	Cash and cash equivalents cash flow statement at beginning of period			109520000
	Cash and cash equivalents cash flow statement at end of period			29170000

Signatory Details
Name of signatory	RISHI PILANI
Designation of person	Managing Director
Place	MUMBAI
Date	15-May-2025